Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Feldman

Showing results (281-290 of 425) with videos related to

Pageof 43
Sort By:
Fetal Diagnosis and Therapy|June 12, 1999
Amnioinfusion in the evaluation of fetal obstructive uropathy: the effect of antibiotic prophylaxis on complication ratesB Feldman, S Hassan, R L Kramer, et al.
Fetal Diagnosis and Therapy|June 12, 1999
Distribution of neural tube defects as a function of maternal weight: no apparent correlationB Feldman, Y Yaron, G Critchfield, et al.
The International Journal of Neuropsychopharmacology|July 24, 2001
Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHDL L Greenhill, J M Perel, G Rudolph, et al.
Journal of the Royal Society of Medicine|September 10, 2020
Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional studyMichael Liu, Brian MacKenna, William B Feldman, et al.
The Hastings Center Report|April 19, 2024
Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman ReplyLeah Z Rand, Daniel P Carpenter, Aaron S Kesselheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Structure and expression of the murine N-myc geneR A DePinho, E Legouy, L B Feldman, et al.
The Hastings Center Report|November 14, 2023
Securing the Trustworthiness of the FDA to Build Public Trust in VaccinesLeah Z Rand, Daniel P Carpenter, Aaron S Kesselheim, et al.
JAMA|November 25, 2024
Differential Legal Protections for Biologics vs Small-Molecule Drugs in the USOlivier J Wouters, Matthew Vogel, William B Feldman, et al.
Journal of Law and the Biosciences|February 25, 2022
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseasesVictor L Van de Wiele, Maximilian Hammer, Ravi Parikh, et al.
Plos Medicine|November 16, 2023
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019Anders Olsen, Reed F Beall, Ryan P Knox, et al.
Pageof 43

Showing results (281-290 of 425) with videos related to

Sort By:
Pageof 43
Fetal Diagnosis and Therapy|June 12, 1999
Amnioinfusion in the evaluation of fetal obstructive uropathy: the effect of antibiotic prophylaxis on complication ratesB Feldman, S Hassan, R L Kramer, et al.
Fetal Diagnosis and Therapy|June 12, 1999
Distribution of neural tube defects as a function of maternal weight: no apparent correlationB Feldman, Y Yaron, G Critchfield, et al.
The International Journal of Neuropsychopharmacology|July 24, 2001
Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHDL L Greenhill, J M Perel, G Rudolph, et al.
Journal of the Royal Society of Medicine|September 10, 2020
Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional studyMichael Liu, Brian MacKenna, William B Feldman, et al.
The Hastings Center Report|April 19, 2024
Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman ReplyLeah Z Rand, Daniel P Carpenter, Aaron S Kesselheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Structure and expression of the murine N-myc geneR A DePinho, E Legouy, L B Feldman, et al.
The Hastings Center Report|November 14, 2023
Securing the Trustworthiness of the FDA to Build Public Trust in VaccinesLeah Z Rand, Daniel P Carpenter, Aaron S Kesselheim, et al.
JAMA|November 25, 2024
Differential Legal Protections for Biologics vs Small-Molecule Drugs in the USOlivier J Wouters, Matthew Vogel, William B Feldman, et al.
Journal of Law and the Biosciences|February 25, 2022
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseasesVictor L Van de Wiele, Maximilian Hammer, Ravi Parikh, et al.
Plos Medicine|November 16, 2023
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019Anders Olsen, Reed F Beall, Ryan P Knox, et al.
Pageof 43